GE HealthCare Technologies Inc. $GEHC Shares Sold by Andra AP fonden

Andra AP fonden reduced its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 93.6% in the 3rd quarter, Holdings Channel reports. The firm owned 3,800 shares of the company’s stock after selling 55,200 shares during the quarter. Andra AP fonden’s holdings in GE HealthCare Technologies were worth $285,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of GEHC. Wedge Capital Management L L P NC acquired a new stake in GE HealthCare Technologies during the 3rd quarter valued at approximately $26,859,000. Valicenti Advisory Services Inc. increased its stake in shares of GE HealthCare Technologies by 22.6% in the third quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock worth $5,115,000 after buying an additional 12,550 shares during the last quarter. Locust Wood Capital Advisers LLC raised its holdings in GE HealthCare Technologies by 7.1% in the third quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock valued at $156,534,000 after acquiring an additional 137,992 shares in the last quarter. Nan Fung Trinity HK Ltd. bought a new position in GE HealthCare Technologies during the 3rd quarter valued at $23,206,000. Finally, Envestnet Asset Management Inc. boosted its stake in GE HealthCare Technologies by 15.8% during the 3rd quarter. Envestnet Asset Management Inc. now owns 338,914 shares of the company’s stock valued at $25,452,000 after acquiring an additional 46,231 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $84.27 on Monday. The firm has a fifty day moving average of $82.38 and a 200-day moving average of $78.46. The company has a market cap of $38.41 billion, a price-to-earnings ratio of 18.48, a price-to-earnings-growth ratio of 1.85 and a beta of 1.03. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $90.26.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. During the same period in the previous year, the business posted $1.45 EPS. GE HealthCare Technologies’s revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is 3.07%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. Barclays boosted their target price on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th. Wells Fargo & Company upped their price objective on GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Citigroup increased their target price on GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Morgan Stanley boosted their price target on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Wednesday, February 4th. Finally, UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their price objective for the stock from $73.00 to $77.00 in a research note on Thursday, January 15th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.